Payment overview · 2025
General Payments
4 reported records · 3 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · PERU, IN · NPI 1134206014
Verified facts
CMS Open Payments records show Michael Mull, MD received $65.83 in general payments during 2025 across 4 reported records.
Abbott Laboratories accounted for 49.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Shingrix.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 83 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 3 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $32.26 | 49.0% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.48 | 28.1% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.09 | 22.9% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $65.83 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $32.26 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $18.48 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| SHINGRIX shingrix |
2025 | Shingrix | 2024 | 72 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
72 | 62 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
83 | 20 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 803 | 194 |
| Levothyroxine Sodium | Levothyroxine Sodium | 507 | 120 |
| Losartan Potassium | Losartan Potassium | 496 | 123 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 482 | 130 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 479 | 81 |
| Omeprazole | Omeprazole | 474 | 129 |
| Amlodipine Besylate | Amlodipine Besylate | 458 | 123 |
| Lisinopril | Lisinopril | 382 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 371 | 107 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 369 | 54 |
| Gabapentin | Gabapentin | 368 | 78 |
| Furosemide | Furosemide | 340 | 82 |
| Metformin Hcl | Metformin Hcl | 322 | 93 |
| Pantoprazole Sodium | Pantoprazole Sodium | 322 | 91 |
| Alprazolam | Alprazolam | 311 | 48 |
| Pioglitazone Hcl | Pioglitazone Hcl | 282 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 261 | 73 |
| Tamsulosin Hcl | Tamsulosin Hcl | 252 | 62 |
| Duloxetine Hcl | Duloxetine Hcl | 234 | 61 |
| Jardiance | Empagliflozin | 234 | 54 |
| Ezetimibe | Ezetimibe | 228 | 61 |
| Simvastatin | Simvastatin | 195 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 190 | 60 |
| Meloxicam | Meloxicam | 168 | 51 |
| Famotidine | Famotidine | 167 | 35 |
| Spironolactone | Spironolactone | 166 | 41 |
| Eliquis | Apixaban | 165 | 33 |
| Carvedilol | Carvedilol | 153 | 39 |
| Tramadol Hcl | Tramadol Hcl | 151 | 37 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 148 | 43 |
| Montelukast Sodium | Montelukast Sodium | 148 | 42 |
| Potassium Chloride | Potassium Chloride | 147 | 43 |
| Alendronate Sodium | Alendronate Sodium | 146 | 43 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 141 | 39 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 139 | 39 |
| Allopurinol | Allopurinol | 138 | 35 |
| Bupropion Xl | Bupropion Hcl | 137 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 136 | 40 |
| Prednisone | Prednisone | 130 | 70 |
| Pregabalin | Pregabalin | 130 | 28 |
| Ropinirole Hcl | Ropinirole Hcl | 128 | 32 |
| Trazodone Hcl | Trazodone Hcl | 123 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 121 | 34 |
| Mounjaro | Tirzepatide | 119 | 22 |
| Trulicity | Dulaglutide | 118 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 115 | 27 |
| Glipizide Er | Glipizide | 115 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 113 | 25 |
| Metformin Hcl Er | Metformin Hcl | 109 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 105 | 30 |
| Morphine Sulfate Er | Morphine Sulfate | 102 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 99 | 14 |
| Buspirone Hcl | Buspirone Hcl | 96 | 26 |
| Clonazepam | Clonazepam | 96 | 20 |
| Topiramate | Topiramate | 96 | 27 |
| Methylprednisolone | Methylprednisolone | 90 | 78 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 86 | 22 |
| Cephalexin | Cephalexin | 83 | 39 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 83 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 80 | 26 |
| Lorazepam | Lorazepam | 80 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 14 |
| Sertraline Hcl | Sertraline Hcl | 75 | 17 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 72 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 22 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 68 | 17 |
| Celecoxib | Celecoxib | 66 | 22 |
| Fentanyl | Fentanyl | 66 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 64 | 23 |
| Bupropion Hcl Sr | Bupropion Hcl | 61 | 14 |
| Ozempic | Semaglutide | 60 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 53 | 12 |
| Risperidone | Risperidone | 52 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 51 | 14 |
| Nitroglycerin | Nitroglycerin | 51 | 24 |
| Warfarin Sodium | Warfarin Sodium | 50 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 47 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 47 | 12 |
| Clonidine Hcl | Clonidine Hcl | 44 | 15 |
| Diazepam | Diazepam | 44 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 43 | 25 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 43 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | 12 |
| Colestipol Hcl | Colestipol Hcl | 41 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 13 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 40 | 40 |
| Promethazine Hcl | Promethazine Hcl | 40 | 12 |
| Sucralfate | Sucralfate | 40 | suppressed |
| Atenolol | Atenolol | 39 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 16 |
| Glipizide | Glipizide | 38 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 38 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 37 | 32 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 21 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Lamotrigine | Lamotrigine | 36 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | 11 |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Aripiprazole | Aripiprazole | 35 | suppressed |
| Memantine Hcl | Memantine Hcl | 35 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 35 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 34 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 34 | 13 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 34 | suppressed |
| Digoxin | Digoxin | 33 | suppressed |
| Finasteride | Finasteride | 33 | suppressed |
| Glimepiride | Glimepiride | 33 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 32 | 31 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 32 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | 13 |
| Mirtazapine | Mirtazapine | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 30 | 16 |
| Ipratropium Bromide | Ipratropium Bromide | 29 | suppressed |
| Ramipril | Ramipril | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Levetiracetam | Levetiracetam | 28 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Estradiol | Estradiol | 27 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Vraylar | Cariprazine Hcl | 26 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 25 | suppressed |
| Methadone Hcl | Methadone Hcl | 25 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 25 | suppressed |
| Cilostazol | Cilostazol | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 22 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Acyclovir | Acyclovir | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 20 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Olanzapine | Olanzapine | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 16 | suppressed |
| Roflumilast | Roflumilast | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Nystatin | Nystatin | 15 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 12 |
| Nexletol | Bempedoic Acid | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Oxycontin | Oxycodone Hcl | 14 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | 13 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Itraconazole | Itraconazole | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Nabumetone | Nabumetone | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Asa-Butalb-Caffeine-Codeine | Codeine/Butalbital/Asa/Caffein | 11 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Xolair | Omalizumab | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $65.83 · 4 records | Abbott Laboratories | Cologuard Collection Kit, FREESTYLE LIBRE 3, SHINGRIX | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error